DIFFUSION PHARMACEUTICALS LLC — Form D
DIFFUSION PHARMACEUTICALS LLC of CHARLOTTESVILLE, VA, a company, filed a Form D exempt-offering notice with the SEC on 2012-10-01. The offering totals $5.5M, of which $5.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2012-10-01
- Form: D
- Accession: 0001171623-12-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $5.5M
- Amount sold: $5.0M
- Remaining: $550K
- Minimum investment: $5K
- Investors: 34
- Date of first sale: 2012-09-14
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-184853
Issuer
- Name: DIFFUSION PHARMACEUTICALS LLC
- CIK: 0001171623
- Entity type: Limited Liability Company
- Jurisdiction: VIRGINIA
- Address: 2020 AVON COURT, #4, CHARLOTTESVILLE, VA, 22902
- Phone: 434-220-0718
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Matthew W Hantzmon | Executive Officer | Charlottesville, VA |
| David Kalergis | Director | Charlottesville, VA |
| David Kalergis | Executive Officer | Charlottesville, VA |
| Mark T Giles | Director | Charlottesville, VA |
| David G Kalergis | Director | Charlottesville, VA |
| David G Kalergis | Executive Officer | Charlottesville, VA |
| Robert W Adams | Director | Charlottesville, VA |
| John L Gainer | Director | Charlottesville, VA |
| John L Gainer | Executive Officer | Charlottesville, VA |
| Ben L Shealy | Executive Officer | Charlottesville, VA |
| David R Jones | Executive Officer | Charlottesville, VA |
| Alan R Levin | Director | Charlottesville, VA |
| Kim L Whitten | Executive Officer | Charlottesville, VA |
| Thomas E Byrne | Director | Bel Air, MD |
| Thomas E Byrne | Executive Officer | Bel Air, MD |
| Matthew L Hantzmon | Executive Officer | Charlottesville, VA |
| Matthew Hantzmon | Executive Officer | Charlottesville, VA |
Other filings by this issuer (6)
More